Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 USD | -2.29% |
|
-13.56% | -17.54% |
06-12 | XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher | MT |
05-30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.54% | 18.46M | |
+18.97% | 45.34B | |
+42.66% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Insider Sell: Viracta Therapeutics